Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer taps a former Novartis exec to lead cancer drug push
BioPharma Dive
Thursday, February 6, 2025 - 11:38am
tags:
Pfizer, Novartis, oncology, cancer
Kenvue's Q4 Sales Miss, Margins Improve
Motley Fool
Thursday, February 6, 2025 - 11:36am
tags:
Kenvue, earnings
Pressure relieved on AZ as details of Chinese probe emerge
Pharmaphorum
Thursday, February 6, 2025 - 11:32am
tags:
AstraZeneca, China
Some federal health websites restored, others still down, after data purge
NPR
Thursday, February 6, 2025 - 11:23am
tags:
Public Health, CDC, Donald Trump
Astellas takes $760M charge, reveals slowdown for eye drug Izervay after regulatory stumbles
Fierce Pharma
Wednesday, February 5, 2025 - 10:54pm
tags:
Astellas, Europe, Izervay
With mid-stage AML win, Kura details dual-track Phase III program for ziftomenib
First Word Pharma
Wednesday, February 5, 2025 - 10:52pm
tags:
Kura Oncology, Kyowa Kirin, ziftomenib, AML
AstraZeneca shareholders say they need clarity on China investigations
MSN/Reuters
Wednesday, February 5, 2025 - 10:46pm
tags:
AstraZeneca, China
Teladoc Health acquires Catapult Health for $65M to boost chronic condition management, at-home testing
Fierce Healthcare
Wednesday, February 5, 2025 - 10:45pm
tags:
Teladoc Health, Catapult Health, telehealth, diagnostics, M&A
Novo Nordisk shares rise on fourth-quarter profit beat, Wegovy sales jump
CNBC
Wednesday, February 5, 2025 - 10:42pm
tags:
Novo Nordisk, Wegovy, earnings
GSK, Pfizer sales of RSV shots slow as vaccination rates ebb
BioPharma Dive
Wednesday, February 5, 2025 - 10:40pm
tags:
GSK, Pfizer, RSV, vaccines
GSK Lifts Long-Term Outlook on Drug Pipeline, Buys Back Shares
Yahoo Finance
Wednesday, February 5, 2025 - 11:30am
tags:
GSK, earnings, stock buyback
Hospitals seek to intervene in J&J lawsuit against HHS to protect valuable drug discounts
Healthcare Dive
Wednesday, February 5, 2025 - 11:29am
tags:
JNJ, legal, 340B, HHS, hospitals
Amgen's early-stage obesity asset slapped with FDA hold
Fierce Biotech
Wednesday, February 5, 2025 - 11:27am
tags:
Amgen, FDA, clinical trials, obesity, AMG 513
Amgen Surpasses Q4 Earnings Forecasts
Motley Fool
Wednesday, February 5, 2025 - 11:26am
tags:
Amgen, earnings
Medtronic recall of brain fluid drainage systems linked to 15 injuries
Medtech Dive
Wednesday, February 5, 2025 - 11:26am
tags:
Medtronic, Medtech, device recalls, FDA, brain fluid drainage, Becker and Exacta
Novo flunks kidney disease trial, again linking obesity prospect to neuropsychiatric side effects
Fierce Biotech
Wednesday, February 5, 2025 - 11:21am
tags:
Novo Nordisk, clinical trials, diabetic kidney disease, Monlunabant
As financial headwinds pick up, pharmas are aiming to squeeze more ROI from their R&D
Pharma Voice
Wednesday, February 5, 2025 - 11:20am
tags:
R&D, drug development
Qlaris sees double as drug reduces eye pressure in pair of phase 2 trials
Fierce Biotech
Wednesday, February 5, 2025 - 11:19am
tags:
Qlaris Bio, clinical trials, ocular hypertension, open angle glaucoma
Liva buys Momenta to bolster digital health platform
Pharmaphorum
Wednesday, February 5, 2025 - 11:18am
tags:
digital health, Medtech, Liva Healthcare, M&A, Momenta
Alys Pharmaceuticals receives regulatory approvals for alopaecia areata drug trial
Clinical Trials Arena
Wednesday, February 5, 2025 - 11:17am
tags:
Alys Pharmaceuticals, FDA, Health Canada, clinical trials, ALY-101, alopecia areata

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.